New injection reduces risk of HIV infection by 96%
A new HIV prevention method of injecting the drug called
Lenacapavir just twice a year has shown groundbreaking results, better than
daily oral medications. In a clinical trial called Purpose-2, led by Emory
University and Grady Health System, ... |